Hillstream BioPharma, Inc. (NASDAQ:HILS – Get Free Report) was down 1.4% on Thursday . The stock traded as low as $1.41 and last traded at $1.44. Approximately 17,521 shares were traded during mid-day trading, a decline of 99% from the average daily volume of 1,388,685 shares. The stock had previously closed at $1.46.
Hillstream BioPharma Stock Down 1.4 %
The company has a 50-day moving average of $1.75 and a 200 day moving average of $2.03. The stock has a market capitalization of $25.35 million, a PE ratio of -2.00 and a beta of 3.08.
About Hillstream BioPharma
Hillstream BioPharma, Inc, a pre-clinical biotechnology company, develops novel therapeutic candidates targeting ferroptosis, an anti-cancer mechanism resulting in iron mediated cell death (IMCD) and targeted immuno-oncology novel biologics for the treatment drug resistant cancers. The company's product candidate is HSB-1216, an IMCD inducer targeting solid tumors.
Featured Stories
- Five stocks we like better than Hillstream BioPharma
- Mastering Discipline: Overcoming Emotional Challenges In Trading
- Penny Stock SurgePays Rises 70%: 1 Reason to Buy, 5 to Sell
- How to Calculate Stock Profit
- Top 3 Beverage Stocks Pouring Out Profits
- How to invest in marijuana stocks in 7 steps
- CarMax and Carvana: Steering the Used Car Market
Receive News & Ratings for Hillstream BioPharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hillstream BioPharma and related companies with MarketBeat.com's FREE daily email newsletter.
